Market Closed -
Toronto S.E.
03:02:39 2024-05-01 pm EDT
|
5-day change
|
1st Jan Change
|
0.065
CAD
|
-7.14%
|
|
-7.14%
|
-31.58%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
32.38
|
20.48
|
30.13
|
51.67
|
15.47
|
17.69
|
Enterprise Value (EV)
1 |
17.22
|
28.6
|
43.31
|
70.83
|
34.69
|
37.44
|
P/E ratio
|
-3.55
x
|
-1.79
x
|
-1.7
x
|
-3.18
x
|
-1.3
x
|
-3.17
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
555
x
|
22.2
x
|
2.06
x
|
1.59
x
|
0.45
x
|
0.47
x
|
EV / Revenue
|
295
x
|
31
x
|
2.96
x
|
2.18
x
|
1.01
x
|
1
x
|
EV / EBITDA
|
-2.51
x
|
-3
x
|
-4.95
x
|
-13.5
x
|
-5.93
x
|
-21.7
x
|
EV / FCF
|
-2.08
x
|
-1.77
x
|
-6.9
x
|
-5.87
x
|
10.8
x
|
-9.7
x
|
FCF Yield
|
-48.1%
|
-56.5%
|
-14.5%
|
-17%
|
9.25%
|
-10.3%
|
Price to Book
|
1.1
x
|
1.06
x
|
2.69
x
|
4.21
x
|
7.2
x
|
-51.7
x
|
Nbr of stocks (in thousands)
|
83,036
|
83,588
|
109,556
|
145,537
|
147,297
|
186,245
|
Reference price
2 |
0.3900
|
0.2450
|
0.2750
|
0.3550
|
0.1050
|
0.0950
|
Announcement Date
|
4/30/19
|
5/15/20
|
5/13/21
|
4/26/22
|
4/17/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.0583
|
0.9239
|
14.65
|
32.47
|
34.4
|
37.57
|
EBITDA
1 |
-6.853
|
-9.52
|
-8.751
|
-5.229
|
-5.847
|
-1.722
|
EBIT
1 |
-7.26
|
-10.1
|
-8.886
|
-5.34
|
-6.098
|
-2.116
|
Operating Margin
|
-12,451.65%
|
-1,092.91%
|
-60.65%
|
-16.44%
|
-17.73%
|
-5.63%
|
Earnings before Tax (EBT)
1 |
-8.656
|
-11.4
|
-15.42
|
-15.28
|
-11.05
|
-4.918
|
Net income
1 |
-8.527
|
-11.4
|
-15.42
|
-15.01
|
-10.93
|
-4.918
|
Net margin
|
-14,623.68%
|
-1,233.72%
|
-105.27%
|
-46.22%
|
-31.78%
|
-13.09%
|
EPS
2 |
-0.1100
|
-0.1371
|
-0.1613
|
-0.1116
|
-0.0810
|
-0.0300
|
Free Cash Flow
1 |
-8.279
|
-16.15
|
-6.28
|
-12.06
|
3.21
|
-3.859
|
FCF margin
|
-14,198.66%
|
-1,748.05%
|
-42.86%
|
-37.15%
|
9.33%
|
-10.27%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/19
|
5/15/20
|
5/13/21
|
4/26/22
|
4/17/23
|
4/25/24
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
7.718
|
9.454
|
8.945
|
8.891
|
8.091
|
9.307
|
9.412
|
7.506
|
9.787
|
10.87
|
EBITDA
1 |
0.1708
|
-0.4938
|
-1.464
|
-0.1496
|
-0.4988
|
-0.5566
|
0.4148
|
-0.6103
|
1.042
|
1.509
|
EBIT
|
-0.7974
|
-2.198
|
-1.674
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-10.33%
|
-23.25%
|
-18.72%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-6.43
|
-4.134
|
-3.026
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-6.43
|
-4.134
|
-3.026
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-83.32%
|
-43.73%
|
-33.83%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.0500
|
-0.0300
|
-0.0200
|
-0.0200
|
-0.0200
|
-0.0200
|
-0.0200
|
-0.0100
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/16/21
|
4/26/22
|
5/18/22
|
8/16/22
|
11/22/22
|
4/17/23
|
5/16/23
|
8/29/23
|
11/21/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
8.12
|
13.2
|
19.2
|
19.2
|
19.7
|
Net Cash position
1 |
15.2
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.8531
x
|
-1.507
x
|
-3.664
x
|
-3.288
x
|
-11.47
x
|
Free Cash Flow
1 |
-8.28
|
-16.1
|
-6.28
|
-12.1
|
3.21
|
-3.86
|
ROE (net income / shareholders' equity)
|
-35.4%
|
-46.8%
|
-101%
|
-127%
|
-154%
|
-545%
|
ROA (Net income/ Total Assets)
|
-14.3%
|
-17.1%
|
-14.4%
|
-8.18%
|
-9.49%
|
-3.49%
|
Assets
1 |
59.56
|
66.78
|
107.3
|
183.5
|
115.2
|
140.7
|
Book Value Per Share
2 |
0.3500
|
0.2300
|
0.1000
|
0.0800
|
0.0100
|
-0
|
Cash Flow per Share
2 |
0.2400
|
0.0100
|
0
|
0.0200
|
0.0200
|
0.0100
|
Capex
1 |
3.71
|
11.5
|
2.32
|
1.8
|
1.07
|
0.54
|
Capex / Sales
|
6,358.88%
|
1,244.39%
|
15.83%
|
5.53%
|
3.1%
|
1.43%
|
Announcement Date
|
4/30/19
|
5/15/20
|
5/13/21
|
4/26/22
|
4/17/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| -31.58% | 9.23M | | +39.33% | 6.11B | | -18.38% | 4.35B | | -9.17% | 3.18B | | +3.98% | 3.16B | | -3.41% | 2.51B | | +48.74% | 1.98B | | -4.82% | 1.74B | | -1.24% | 1.63B | | -8.96% | 1.6B |
Alternative Medicine
|